脂質ナノ粒子の世界市場規模調査・予測：タイプ別（固体脂質ナノ粒子（SLN）、ナノ構造脂質担体（NLC）、その他）、用途別、エンドユーザー別、地域別分析、2022-2029年

脂質ナノ粒子の世界市場は、2021年に約6億8750万米ドルと評価され、予測期間2022-2029年には13.6%以上の健全な成長率で成長すると予測されています。

脂質ナノ粒子は、脂質で構成されるナノ粒子の一種です。これは、新規の医薬品製剤および新規の医薬品デリバリーシステムであり、がんなどの疾患の治療において核酸を運ぶために使用されています。mRNAワクチンメーカーからの脂質システムに対する需要の急増、ベクターとしての遺伝子治療におけるナノ粒子の採用の増加、製薬・バイオテクノロジー企業の増加と相まって、世界中で市場の需要を規定している主な要因となっています。

特に標的部位に薬剤を送達するための革新的で個別化された医療が重視されるようになったことが、市場需要の主な促進要因となっています。Statistaによると、個別化医療の世界市場は2019年に約1兆9,800億米ドル規模であり、2022年には2兆7,700億米ドルに増加すると予想されています。結果的に、個別化医療への嗜好の高まりは、腫瘍学および神経学関連の薬剤を送達する際のキャリアとしての脂質ナノ粒子の採用を促進し、市場成長を加速させています。さらに、研究開発活動への投資の増加や、特徴的な製品の開発に対する市場関係者のイニシアティブの高まりは、予測期間中にさまざまな有利な機会をもたらしています。しかし、脂質ナノ粒子の使用に関連する厳しい規制の賦課といくつかの副作用が、2022-2029年の予測期間を通して市場成長の妨げとなっています。

脂質ナノ粒子の世界市場調査のために考慮された主要地域は、アジア太平洋、北米、欧州、中南米、世界のその他の地域です。北米は、製品承認取得に向けた注力度の高まりと主要プレイヤーの強固な存在感により、収益面で市場を独占しています。一方、アジア太平洋地域は、人口増加、ライフスタイルの急速な変化、栄養補助食品に対する需要の高まりなどの要因から、予測期間中に最も高いCAGRで成長すると予想されています。

本調査の目的は、近年におけるさまざまなセグメントおよび国の市場規模を定義し、今後数年間の値を予測することです。本レポートは、調査対象国における産業の質的・量的な側面を取り込むように設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細な情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場の潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

• 市場スナップショット
• 世界市場・セグメント別市場推定・予測、2019-2029年
  • 脂質ナノ粒子市場、地域別、2019-2029年
  • 脂質ナノ粒子市場、タイプ別、2019-2029年
  • 脂質ナノ粒子市場：用途別、2019-2029年
  • 脂質ナノ粒子市場：エンドユーザー別、2019-2029年
• 主な動向
• 調査手法の紹介
• 調査前提条件

第2章 脂質ナノ粒子の世界市場定義と範囲

• 調査の目的
• 市場の定義と範囲
  • 調査対象範囲
  • 産業の進化
• 調査対象年
• 通貨換算レート

第3章 脂質ナノ粒子の世界市場力学

• 脂質ナノ粒子市場のインパクト分析（2019年～2029年）
  • 市場促進要因
    • ベクターとしての遺伝子治療におけるナノ粒子の採用の増加
    • 革新的で個別化された医療への重点化の高まり
  • 市場の課題
    • 厳しい規制の賦課
    • 脂質ナノ粒子の使用に関連するいくつかの副作用
  • 市場機会
    • 研究開発活動への投資の増加
    • 明確な製品開発に対する市場プレイヤーのイニシアチブの増加

第4章 脂質ナノ粒子の世界市場産業分析

• ポーターの5フォースモデル
  • 供給企業の交渉力
  • 買い手の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争企業間の敵対関係
• ポーターの5フォースモデルへの未来的アプローチ（2019-2029年）
• PEST分析
  • 政治的
  • 経済的
  • 社会的
  • 技術的
• トップ投資機会
• 主要成功戦略
• 業界専門家別展望
• アナリストの結論・提言

第5章 リスクアセスメント：COVID-19のインパクト

• COVID-19が業界に与える全体的な影響の評価
• COVID-19以前とCOVID-19以後の市場シナリオ

第6章 脂質ナノ粒子の世界市場、タイプ別

• 市場スナップショット
• 脂質ナノ粒子の世界市場、タイプ別性能-ポテンシャル分析
• 脂質ナノ粒子の世界市場タイプ別推定・予測2019～2029年
• 脂質ナノ粒子市場、サブセグメント分析
  • 固体脂質ナノ粒子（SLN）
  • ナノ構造脂質キャリア（NLC）
  • その他

第7章：脂質ナノ粒子の世界市場：用途別

• 市場スナップショット
• 脂質ナノ粒子の世界市場：用途別実績-ポテンシャル分析
• 脂質ナノ粒子の世界市場、用途別推定・予測2019-2029年
• 脂質ナノ粒子市場、サブセグメント分析
  • 治療薬
  • 調査

第8章 脂質ナノ粒子の世界市場：エンドユーザー別

• 市場スナップショット
• 脂質ナノ粒子の世界市場、エンドユーザー別実績-ポテンシャル分析
• 脂質ナノ粒子の世界市場、エンドユーザー別推定・予測2019～2029年
• 脂質ナノ粒子市場、サブセグメント分析
  • 製薬会社、バイオテクノロジー企業
  • 学術・研究機関
  • その他

第9章：脂質ナノ粒子の世界市場：地域別分析

• 脂質ナノ粒子市場、地域別市場スナップショット
• 北米
  • 米国
    • タイプ別の推定・予測、2019-2029年
    • アプリケーション別の推定・予測、2019年～2029年
    • エンドユーザー別の推定・予測、2019年～2029年
  • カナダ
• 欧州脂質ナノ粒子市場スナップショット
  • 英国
  • ドイツ
  • フランス
  • スペイン
  • イタリア
  • その他の欧州地域
• アジア太平洋地域の脂質ナノ粒子市場スナップショット
  • 中国
  • インド
  • 日本
  • オーストラリア
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカの脂質ナノ粒子市場スナップショット
  • ブラジル
  • メキシコ
  • その他のラテンアメリカ地域
• 世界のその他の地域

第10章 競合情報

• トップ市場戦略
• 企業プロファイル
  • Merck KGaA
    • 主要情報
    • 概要
    • 財務情報（データの入手状況により異なります）
    • 製品概要
    • 最近の動向
  • Evonik Industries AG
  • Gattefosse
  • Precision NanoSystems
  • ABITEC Corporation
  • Nippon Oil & Fats Corporation
  • Lipoid GmbH
  • BASF SE
  • Dishman Group
  • IOI Oleo GmbH

第11章 調査プロセス

• 調査プロセス
  • データマイニング
  • 分析
  • 市場推定
  • バリデーション
  • 出版
• 調査属性
• 調査の前提条件

LIST OF TABLES

• TABLE 1. Global Lipid Nanoparticles Market, report scope
• TABLE 2. Global Lipid Nanoparticles Market estimates & forecasts by Region 2019-2029 (USD Million)
• TABLE 3. Global Lipid Nanoparticles Market estimates & forecasts by Type 2019-2029 (USD Million)
• TABLE 4. Global Lipid Nanoparticles Market estimates & forecasts by Application 2019-2029 (USD Million)
• TABLE 5. Global Lipid Nanoparticles Market estimates & forecasts by End User 2019-2029 (USD Million)
• TABLE 6. Global Lipid Nanoparticles Market by segment, estimates & forecasts, 2019-2029 (USD Million)
• TABLE 7. Global Lipid Nanoparticles Market by region, estimates & forecasts, 2019-2029 (USD Million)
• TABLE 8. Global Lipid Nanoparticles Market by segment, estimates & forecasts, 2019-2029 (USD Million)
• TABLE 9. Global Lipid Nanoparticles Market by region, estimates & forecasts, 2019-2029 (USD Million)
• TABLE 10. Global Lipid Nanoparticles Market by segment, estimates & forecasts, 2019-2029 (USD Million)
• TABLE 11. Global Lipid Nanoparticles Market by region, estimates & forecasts, 2019-2029 (USD Million)
• TABLE 12. Global Lipid Nanoparticles Market by segment, estimates & forecasts, 2019-2029 (USD Million)
• TABLE 13. Global Lipid Nanoparticles Market by region, estimates & forecasts, 2019-2029 (USD Million)
• TABLE 14. Global Lipid Nanoparticles Market by segment, estimates & forecasts, 2019-2029 (USD Million)
• TABLE 15. Global Lipid Nanoparticles Market by region, estimates & forecasts, 2019-2029 (USD Million)
• TABLE 16. U.S. Lipid Nanoparticles Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 17. U.S. Lipid Nanoparticles Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 18. U.S. Lipid Nanoparticles Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 19. Canada Lipid Nanoparticles Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 20. Canada Lipid Nanoparticles Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 21. Canada Lipid Nanoparticles Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 22. UK Lipid Nanoparticles Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 23. UK Lipid Nanoparticles Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 24. UK Lipid Nanoparticles Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 25. Germany Lipid Nanoparticles Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 26. Germany Lipid Nanoparticles Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 27. Germany Lipid Nanoparticles Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 28. France Lipid Nanoparticles Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 29. France Lipid Nanoparticles Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 30. France Lipid Nanoparticles Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 31. Italy Lipid Nanoparticles Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 32. Italy Lipid Nanoparticles Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 33. Italy Lipid Nanoparticles Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 34. Spain Lipid Nanoparticles Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 35. Spain Lipid Nanoparticles Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 36. Spain Lipid Nanoparticles Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 37. RoE Lipid Nanoparticles Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 38. RoE Lipid Nanoparticles Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 39. RoE Lipid Nanoparticles Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 40. China Lipid Nanoparticles Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 41. China Lipid Nanoparticles Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 42. China Lipid Nanoparticles Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 43. India Lipid Nanoparticles Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 44. India Lipid Nanoparticles Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 45. India Lipid Nanoparticles Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 46. Japan Lipid Nanoparticles Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 47. Japan Lipid Nanoparticles Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 48. Japan Lipid Nanoparticles Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 49. South Korea Lipid Nanoparticles Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 50. South Korea Lipid Nanoparticles Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 51. South Korea Lipid Nanoparticles Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 52. Australia Lipid Nanoparticles Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 53. Australia Lipid Nanoparticles Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 54. Australia Lipid Nanoparticles Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 55. RoAPAC Lipid Nanoparticles Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 56. RoAPAC Lipid Nanoparticles Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 57. RoAPAC Lipid Nanoparticles Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 58. Brazil Lipid Nanoparticles Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 59. Brazil Lipid Nanoparticles Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 60. Brazil Lipid Nanoparticles Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 61. Mexico Lipid Nanoparticles Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 62. Mexico Lipid Nanoparticles Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 63. Mexico Lipid Nanoparticles Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 64. RoLA Lipid Nanoparticles Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 65. RoLA Lipid Nanoparticles Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 66. RoLA Lipid Nanoparticles Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 67. Row Lipid Nanoparticles Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 68. Row Lipid Nanoparticles Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 69. Row Lipid Nanoparticles Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 70. List of secondary sources, used in the study of global Lipid Nanoparticles Market
• TABLE 71. List of primary sources, used in the study of global Lipid Nanoparticles Market
• TABLE 72. Years considered for the study
• TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

• FIG 1. Global Lipid Nanoparticles Market, research methodology
• FIG 2. Global Lipid Nanoparticles Market, Market estimation techniques
• FIG 3. Global Market size estimates & forecast methods
• FIG 4. Global Lipid Nanoparticles Market, key trends 2021
• FIG 5. Global Lipid Nanoparticles Market, growth prospects 2022-2029
• FIG 6. Global Lipid Nanoparticles Market, porters 5 force model
• FIG 7. Global Lipid Nanoparticles Market, pest analysis
• FIG 8. Global Lipid Nanoparticles Market, value chain analysis
• FIG 9. Global Lipid Nanoparticles Market by segment, 2019 & 2029 (USD Million)
• FIG 10. Global Lipid Nanoparticles Market by segment, 2019 & 2029 (USD Million)
• FIG 11. Global Lipid Nanoparticles Market by segment, 2019 & 2029 (USD Million)
• FIG 12. Global Lipid Nanoparticles Market by segment, 2019 & 2029 (USD Million)
• FIG 13. Global Lipid Nanoparticles Market by segment, 2019 & 2029 (USD Million)
• FIG 14. Global Lipid Nanoparticles Market, regional snapshot 2019 & 2029
• FIG 15. North America Lipid Nanoparticles Market 2019 & 2029 (USD Million)
• FIG 16. Europe Lipid Nanoparticles Market 2019 & 2029 (USD Million)
• FIG 17. Asia pacific Lipid Nanoparticles Market 2019 & 2029 (USD Million)
• FIG 18. Latin America Lipid Nanoparticles Market 2019 & 2029 (USD Million)
• FIG 19. Global Lipid Nanoparticles Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

Global Lipid Nanoparticles Market is valued at approximately USD 687.5 million in 2021 and is anticipated to grow with a healthy growth rate of more than 13.6% over the forecast period 2022-2029. Lipid nanoparticles are a type of a nanoparticle that is composed of lipids. It is a novel pharmaceutical formulation and new pharmaceutical drug delivery system that are used are used to carry nucleic acids in the treatment of diseases such as cancer. The surging demand for lipid systems from mRNA vaccine manufacturers, rising adoption of nanoparticles in gene therapy as vector, coupled with the increasing number of pharmaceutical & biotechnology companies are the primary factors that are stipulating the market demand across the globe.

The rising emphasis on innovative and personalized medicine to deliver drugs at specifically targeted sites is a chief driving factor for the market demand. According to Statista, the global market for personalized medicine was worth approximately USD 1,980 billion in 2019 and is expected to increase to USD 2,770 billion by the year 2022. Consequentially, the increasing preference towards personalized medicines is fueling the adoption of lipid nanoparticles as a carrier in delivering oncology and neurology-related drugs, which is accelerating market growth. Moreover, the rising investment on R&D activities, as well as the increasing initiatives by market players for the development of distinct products are presenting various lucrative opportunities over the forecasting years. However, the imposition of stringent regulations and several side effects associated with the use of lipid nanoparticles are hindering the market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Lipid Nanoparticles Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the growing focus on receiving product approvals and the robust presence of the major players. Whereas, the Asia Pacific is also expected to grow with the highest CAGR during the forecast period, owing to factors such as rising populations, rapidly changing lifestyles, and rising demand for nutraceutical therapies in the market space.

Major market players included in this report are:

Merck KGaA

Evonik Industries AG

Gattefosse

Precision NanoSystems

ABITEC Corporation

Nippon Oil & Fats Corporation

Lipoid GmbH

BASF SE

Dishman Group

IOI Oleo GmbH

Recent Developments in the Market:

• In October 2022, Polypeptide Therapeutic Solutions (PTS) announced the expansion of its drug delivery capabilities which includes novel nanoparticle formulation and functional lipid excipients.
• In May 2022, Gattefosse declared the establishment of a new manufacturing facility in the U.S. to manufacture lipid-based specialty ingredients for cosmetic and pharmaceutical industries.
• In June 2021, Danaher unveils the company's acquisition with the Precision NanoSystems (PNI), which aims on developing PNI mRNA technology to launch vaccines for curing unmet conditions such as cancer and genetic diseases.

Global Lipid Nanoparticles Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered: Type, Application, End User, Region

Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

Solid Lipid Nanoparticles (SLNs)

Nanostructured Lipid Carriers (NLCs)

Others

By Application:

Therapeutics

Research

By End User:

Pharmaceutical & Biotechnology Companies

Academic & Research Institutes

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

RoLA

Rest of the World

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Million)
  • 1.2.1. Lipid Nanoparticles Market, by Region, 2019-2029 (USD Million)
  • 1.2.2. Lipid Nanoparticles Market, by Type, 2019-2029 (USD Million)
  • 1.2.3. Lipid Nanoparticles Market, by Application, 2019-2029 (USD Million)
  • 1.2.4. Lipid Nanoparticles Market, by End User, 2019-2029 (USD Million)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Lipid Nanoparticles Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Scope of the Study
  • 2.2.2. Industry Evolution
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Lipid Nanoparticles Market Dynamics

• 3.1. Lipid Nanoparticles Market Impact Analysis (2019-2029)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Increasing adoption of nanoparticles in gene therapy as vector
    • 3.1.1.2. Rising emphasis on innovative and personalized medicine
  • 3.1.2. Market Challenges
    • 3.1.2.1. Imposition of stringent regulations
    • 3.1.2.2. Several side effects associated with the use of lipid nanoparticles
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Rising investment on R&D activities
    • 3.1.3.2. Increasing initiatives by market players for the development of distinct products

Chapter 4. Global Lipid Nanoparticles Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
• 4.4. Top investment opportunity
• 4.5. Top winning strategies
• 4.6. Industry Experts Prospective
• 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

• 5.1. Assessment of the overall impact of COVID-19 on the industry
• 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Lipid Nanoparticles Market, by Type

• 6.1. Market Snapshot
• 6.2. Global Lipid Nanoparticles Market by Type, Performance - Potential Analysis
• 6.3. Global Lipid Nanoparticles Market Estimates & Forecasts by Type 2019-2029 (USD Million)
• 6.4. Lipid Nanoparticles Market, Sub Segment Analysis
  • 6.4.1. Solid Lipid Nanoparticles (SLNs)
  • 6.4.2. Nanostructured Lipid Carriers (NLCs)
  • 6.4.3. Others

Chapter 7. Global Lipid Nanoparticles Market, by Application

• 7.1. Market Snapshot
• 7.2. Global Lipid Nanoparticles Market by Application, Performance - Potential Analysis
• 7.3. Global Lipid Nanoparticles Market Estimates & Forecasts by Application 2019-2029 (USD Million)
• 7.4. Lipid Nanoparticles Market, Sub Segment Analysis
  • 7.4.1. Therapeutics
  • 7.4.2. Research

Chapter 8. Global Lipid Nanoparticles Market, by End User

• 8.1. Market Snapshot
• 8.2. Global Lipid Nanoparticles Market by End User, Performance - Potential Analysis
• 8.3. Global Lipid Nanoparticles Market Estimates & Forecasts by End User 2019-2029 (USD Million)
• 8.4. Lipid Nanoparticles Market, Sub Segment Analysis
  • 8.4.1. Pharmaceutical & Biotechnology Companies
  • 8.4.2. Academic & Research Institutes
  • 8.4.3. Others

Chapter 9. Global Lipid Nanoparticles Market, Regional Analysis

• 9.1. Lipid Nanoparticles Market, Regional Market Snapshot
• 9.2. North America Lipid Nanoparticles Market
  • 9.2.1. U.S. Lipid Nanoparticles Market
    • 9.2.1.1. Type breakdown estimates & forecasts, 2019-2029
    • 9.2.1.2. Application breakdown estimates & forecasts, 2019-2029
    • 9.2.1.3. End User breakdown estimates & forecasts, 2019-2029
  • 9.2.2. Canada Lipid Nanoparticles Market
• 9.3. Europe Lipid Nanoparticles Market Snapshot
  • 9.3.1. U.K. Lipid Nanoparticles Market
  • 9.3.2. Germany Lipid Nanoparticles Market
  • 9.3.3. France Lipid Nanoparticles Market
  • 9.3.4. Spain Lipid Nanoparticles Market
  • 9.3.5. Italy Lipid Nanoparticles Market
  • 9.3.6. Rest of Europe Lipid Nanoparticles Market
• 9.4. Asia-Pacific Lipid Nanoparticles Market Snapshot
  • 9.4.1. China Lipid Nanoparticles Market
  • 9.4.2. India Lipid Nanoparticles Market
  • 9.4.3. Japan Lipid Nanoparticles Market
  • 9.4.4. Australia Lipid Nanoparticles Market
  • 9.4.5. South Korea Lipid Nanoparticles Market
  • 9.4.6. Rest of Asia Pacific Lipid Nanoparticles Market
• 9.5. Latin America Lipid Nanoparticles Market Snapshot
  • 9.5.1. Brazil Lipid Nanoparticles Market
  • 9.5.2. Mexico Lipid Nanoparticles Market
  • 9.5.3. Rest of Latin America Lipid Nanoparticles Market
• 9.6. Rest of The World Lipid Nanoparticles Market

Chapter 10. Competitive Intelligence

• 10.1. Top Market Strategies
• 10.2. Company Profiles
  • 10.2.1. Merck KGaA
    • 10.2.1.1. Key Information
    • 10.2.1.2. Overview
    • 10.2.1.3. Financial (Subject to Data Availability)
    • 10.2.1.4. Product Summary
    • 10.2.1.5. Recent Developments
  • 10.2.2. Evonik Industries AG
  • 10.2.3. Gattefosse
  • 10.2.4. Precision NanoSystems
  • 10.2.5. ABITEC Corporation
  • 10.2.6. Nippon Oil & Fats Corporation
  • 10.2.7. Lipoid GmbH
  • 10.2.8. BASF SE
  • 10.2.9. Dishman Group
  • 10.2.10. IOI Oleo GmbH

Chapter 11. Research Process

• 11.1. Research Process
  • 11.1.1. Data Mining
  • 11.1.2. Analysis
  • 11.1.3. Market Estimation
  • 11.1.4. Validation
  • 11.1.5. Publishing
• 11.2. Research Attributes
• 11.3. Research Assumption